Company news
Heron Therapeutics, Inc. news in 2020
Heron Therapeutics, Inc.'s news releases, calls and decks from 2020, newest first.
Heron Therapeutics Resubmits New Drug Application to FDA for HTX-011 for the Treatment of Postoperative Pain
November 12, 2020
Heron Therapeutics Announces Financial Results for the Three and Nine Months Ended September 30, 2020 and Highlights Recent Corporate Updates
November 4, 2020
Heron Therapeutics Receives European Commission Authorization for ZYNRELEF™ (HTX-011) for the Treatment of Postoperative Pain
September 27, 2020
Heron Therapeutics Announces Publication of Results from EPOCH 2 Follow-On Study, a Phase 2b Study of HTX-011 in Patients Undergoing Hernia Repair Surgery
September 15, 2020
Heron Therapeutics to Present at Cantor Virtual Global Healthcare Conference
September 10, 2020
Heron Therapeutics Announces Successful Outcome of FDA Type A Meeting to Discuss HTX-011 for the Management of Postoperative Pain
September 7, 2020
Heron Therapeutics Announces Financial Results for the Three and Six Months Ended June 30, 2020 and Highlights Recent Corporate Updates
August 4, 2020
Heron Therapeutics Receives Positive CHMP Opinion for ZYNRELEF™ (HTX-011) for the Management of Postoperative Pain
July 23, 2020
Heron Therapeutics Announces Initiation of Phase 2 Clinical Study of CINVANTI® for the Treatment of COVID-19
July 15, 2020
Heron Therapeutics Receives Complete Response Letter for HTX-011 for the Management of Postoperative Pain
June 28, 2020
Heron Therapeutics Announces Publication of Results from Study 209, a Phase 2b Study of HTX-011 in Patients Undergoing Total Knee Arthroplasty
June 3, 2020
Heron Therapeutics Announces Initiation of Phase 1b/2 Clinical Study of HTX-034 for the Treatment of Postoperative Pain
May 17, 2020
Heron Therapeutics Announces Financial Results for the Three Months Ended March 31, 2020 and Highlights Recent Corporate Updates
May 5, 2020
Heron Therapeutics to Present at the 19th Annual Needham Virtual Healthcare Conference
April 8, 2020
Heron Therapeutics Announces Financial Results for the Three and Twelve Months Ended December 31, 2019 and Highlights Recent Corporate Updates
March 1, 2020
Heron Therapeutics to Present at the 40th Annual Cowen Healthcare Conference
February 24, 2020
Heron Therapeutics Announces FDA Extension of Review Period for NDA for HTX-011 for the Management of Postoperative Pain
February 18, 2020
Heron Therapeutics to Present at the 9th Annual SVB Leerink Global Healthcare Conference
February 17, 2020
Heron Therapeutics Highlights Progress in Pain Management and CINV Franchises
January 12, 2020
Decks in 2020
- J.P. Morgan Healthcare Conference 2020
Conference · 64 slides · Jan 13, 2020